Trials / Completed
CompletedNCT04603677
Northern Colorado COVID-19 Biobank
Northern Colorado Coronavirus Biobank: A Biorepository for Acute and Convalescent Patient Samples From Coloradoans Infected With SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 148 (actual)
- Sponsor
- Colorado State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The NoCo-CoBio Project is a biobanking effort to store and preserve saliva, nasopharyngeal, stool and blood specimens from SARS-CoV-2 PCR (polymerase chain reaction) positive individuals.
Detailed description
The investigators have created a biorepository of stool, saliva, nasopharyngeal swab specimens, peripheral blood mononuclear cells, serum, and plasma from SARS-CoV-2 infected individuals for research purposes. The multifaceted biorepository will be used to establish markers predicting various presentations of COVID-19 (coronavirus disease 2019).
Conditions
Timeline
- Start date
- 2020-07-08
- Primary completion
- 2023-02-28
- Completion
- 2023-02-28
- First posted
- 2020-10-27
- Last updated
- 2023-03-21
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04603677. Inclusion in this directory is not an endorsement.